206 related articles for article (PubMed ID: 32494136)
1. Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge (
Shady NH; Khattab AR; Ahmed S; Liu M; Quinn RJ; Fouad MA; Kamel MS; Muhsinah AB; Krischke M; Mueller MJ; Abdelmohsen UR
Int J Nanomedicine; 2020; 15():3377-3389. PubMed ID: 32494136
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.
Fujimoto Y; Salam KA; Furuta A; Matsuda Y; Fujita O; Tani H; Ikeda M; Kato N; Sakamoto N; Maekawa S; Enomoto N; de Voogd NJ; Nakakoshi M; Tsubuki M; Sekiguchi Y; Tsuneda S; Akimitsu N; Noda N; Yamashita A; Tanaka J; Moriishi K
PLoS One; 2012; 7(11):e48685. PubMed ID: 23144928
[TBL] [Abstract][Full Text] [Related]
3. Antiviral potential of green synthesized silver nanoparticles of
Haggag EG; Elshamy AM; Rabeh MA; Gabr NM; Salem M; Youssif KA; Samir A; Bin Muhsinah A; Alsayari A; Abdelmohsen UR
Int J Nanomedicine; 2019; 14():6217-6229. PubMed ID: 31496682
[TBL] [Abstract][Full Text] [Related]
4. Identification of a 3-Alkylpyridinium Compound from the Red Sea Sponge
O'Rourke A; Kremb S; Duggan BM; Sioud S; Kharbatia N; Raji M; Emwas AH; Gerwick WH; Voolstra CR
Molecules; 2018 Jun; 23(6):. PubMed ID: 29912151
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Potential of Green Synthesized Silver Nanoparticles of the Soft Coral
Abdelhafez OH; Ali TFS; Fahim JR; Desoukey SY; Ahmed S; Behery FA; Kamel MS; Gulder TAM; Abdelmohsen UR
Int J Nanomedicine; 2020; 15():5345-5360. PubMed ID: 32801693
[TBL] [Abstract][Full Text] [Related]
6. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
[TBL] [Abstract][Full Text] [Related]
7. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
8. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
9. Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes.
Lim SK; Othman R; Yusof R; Heh CH
Chem Biol Drug Des; 2021 Jan; 97(1):28-40. PubMed ID: 32657543
[TBL] [Abstract][Full Text] [Related]
10. Different Culture Metabolites of the Red Sea Fungus Fusarium equiseti Optimize the Inhibition of Hepatitis C Virus NS3/4A Protease (HCV PR).
Hawas UW; Al-Farawati R; Abou El-Kassem LT; Turki AJ
Mar Drugs; 2016 Oct; 14(10):. PubMed ID: 27775589
[TBL] [Abstract][Full Text] [Related]
11. In silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening.
Wadood A; Riaz M; Uddin R; Ul-Haq Z
PLoS One; 2014; 9(2):e89109. PubMed ID: 24551230
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
[TBL] [Abstract][Full Text] [Related]
13. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
[TBL] [Abstract][Full Text] [Related]
14. PBDE: structure-activity studies for the inhibition of hepatitis C virus NS3 helicase.
Salam KA; Furuta A; Noda N; Tsuneda S; Sekiguchi Y; Yamashita A; Moriishi K; Nakakoshi M; Tani H; Roy SR; Tanaka J; Tsubuki M; Akimitsu N
Molecules; 2014 Apr; 19(4):4006-20. PubMed ID: 24699145
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation.
Ndjomou J; Kolli R; Mukherjee S; Shadrick WR; Hanson AM; Sweeney NL; Bartczak D; Li K; Frankowski KJ; Schoenen FJ; Frick DN
Antiviral Res; 2012 Nov; 96(2):245-55. PubMed ID: 22940425
[TBL] [Abstract][Full Text] [Related]
16. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
17. Designing and molecular docking of cyclic peptides against HCV NS3 protease.
Masoud MS; Bukhari SA; Qasim M; Naqvi SAR; Ashfaq UA
Pak J Pharm Sci; 2017 Sep; 30(5(Supplementary)):1965-1969. PubMed ID: 29105629
[TBL] [Abstract][Full Text] [Related]
18.
Ng TI; Tripathi R; Reisch T; Lu L; Middleton T; Hopkins TA; Pithawalla R; Irvin M; Dekhtyar T; Krishnan P; Schnell G; Beyer J; McDaniel KF; Ma J; Wang G; Jiang LJ; Or YS; Kempf D; Pilot-Matias T; Collins C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084747
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
[TBL] [Abstract][Full Text] [Related]
20. Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication.
Mukherjee S; Weiner WS; Schroeder CE; Simpson DS; Hanson AM; Sweeney NL; Marvin RK; Ndjomou J; Kolli R; Isailovic D; Schoenen FJ; Frick DN
ACS Chem Biol; 2014 Oct; 9(10):2393-403. PubMed ID: 25126694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
